Related Experiment Video
Updated: Feb 20, 2026

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024
Cognitive decline in U.S. military veterans: risk factors and clinical implications
Rob J MacLennan1,2, Benjamin A Chapin1,3,4, Laurence M Solberg1,5,6
1Geriatric Research, Education, and Clinical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL, United States.
Abstract:
Military veterans have higher aggregate prevalence of risk factors for cognitive decline than non-veterans. This includes risk factors like diabetes, chronic pain, smoking, depression, and more. The disparity in prevalences is due in part to the unique experiences and exposures of their military service. Alzheimer's disease and other dementias are debilitating diseases with large financial and logistical burdens. These burdens are held by the patient, their family, friends, and caregivers, as well as healthcare professionals, and healthcare systems. Standardized screening for these risk factors may be helpful for understanding risk profiles that lead to cognitive decline. Additionally, screening must occur early to encourage early intervention and behavioral modifications and to reduce these burdens. This perspective presents the prevalence of risk factors for cognitive decline in the Veteran and non-veteran populations and proposes an approach to managing risk factors in Veterans.
More Related Videos
Related Concept Videos
Cognitive Development During Adulthood
Drug Dosing: Geriatric Patients
Dementia
The progression of dementia is generally gradual....
Pharmacodynamics in Geriatric Patients: Effects of Age
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

